Pacilia (Ethinylestradiol, Levonorgestrel)

Ethinylestradiol, the active ingredient in Pacilia, is a synthetic estrogen presented as a combined oral contraceptive for systemic use. It works alongside levonorgestrel to prevent pregnancy in women of reproductive age.

GNH USA supplies Pacilia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pacilia combines ethinylestradiol and levonorgestrel as a combined oral contraceptive, acting on the hormonal regulation pathway to prevent pregnancy. - Contraception: Provides reliable, reversible prevention of pregnancy when taken as directed. - Menstrual cycle regulation: Helps achieve more predictable menstrual bleeding patterns. - Acne management: Offers hormonal control that can reduce acne severity in some women. - Endometriosis symptom relief: May lessen dysmenorrhea associated with endometrious tissue. - Ovarian cyst prevention: Decreases the incidence of functional ovarian cysts. - Hormone‑dependent tumor treatment : Provides the ‑